Drug paraphernalia laws and injection-related infectious disease risk among drug injectors

Journal of Drug Issues

Volumn 29, Issue 1, 1999, Pages 1-16

  Bluthenthal, Ricky N ^a   Kral, Alex H ^b   Erringer, Elizabeth A ^b   Edlin, Brian R ^b  

^a RAND CORPORATION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ARTICLE; DRUG USE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; INFECTION; INFECTION RISK; INJECTION; LAW; MAJOR CLINICAL STUDY; MALE; NEEDLE; SYRINGE;

EID: 0032959160     PISSN: 00220426     EISSN: None     Source Type: Journal    
DOI: 10.1177/002204269902900101     Document Type: Article

References (48)

1. Alter, M.J. 1993 The detection, transmission, and outcome of hepatitis C virus infection. Infectious Agents and Disease 2:155-166.
2. American Medical Association 1996 A Physican Guide to HIV Prevent. Chicago, IL: American Medical Association.
3. Bluthenthal, R.N. 1998 Syringe exchange as a social movement: A case study of harm reduction in Oakland, California. Substance Use and Misuse 33:1147-1171.
4. Bluthenthal, R.N., E.A. Erringer, A.H. Kral, and B.R. Edlin 1998 Factors associated with syringe sharing among injection drug users (IDUs) following the implementation of a medium-sized syringe exchange program (SEP). In 126th American Public Health Association Meeting. Washington, D.C.
5. Bluthenthal, R.N., A.H. Kral, E.A. Erringer, and B.R. Edlin 1998 Use of an illegal syringe exchange use and injection-related risk behaviors among street-recruited injeciton drug users in Oakland, California, 1992-1995. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18:505-511.
6. Bluthenthal, R.N., A.H. Kral, J. Lorvick, and J.K. Watters 1997 Impact of law enforcement on syringe exchange programs: A look at Oakland and San Francisco. Medical Anthropology 18:61-83.
7. Bluthenthal, R.N. and J.K. Watters 1995 Multimethod research: From targeted sampling to HIV risk behaviors. In Qualitative Methods in the Prevention of Drug Abuse and HIV Research, vol. 157, E. Lambert, R.S. Ashery and R.H. Needle (eds.). NIDA Research Monograph, 212-230. Rockville, MD: National Institute on Drug Abuse.
8. Booth, R.E., S.K. Koester, C.S. Reichardt, and J.T. Brewster 1993 Quantitative and qualitative methods to assess behavioral change among injection drug users. Drugs and Society 7:161-183.
9. Bourgois, P., M. Lettiere, and J. Quesada 1997 Social misery and the sanctions of substance abuse: Confronting HIV risk among homeless heroin addicts in San Francisco. Social Problems 44:155-173.
10. Burris, S., D. Finucane, H. Gallagher, and J. Grace 1996 The legal strategies used in operating syringe exchange programs in the United States. American Journal of Public Health 86:1161-1166.
11. Case, P., T. Meehan, and T.S. Jones 1998 Arrests and incaraceration of injection drug users for syringe possession in Massachusetts: Implications for HIV prevention. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18(suppl 1):S71-S75.
12. D'Aquila, R.T., L.R. Peterson, A.B. Williams, and A.E. Williams 1989 Race/ethnicity as a risk factor for HIV-1 infection among Connecticut intravenous drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 2:503-513.
13. Dasgupta, S., S.R. Friedman, B. Jose, and A. Neaigus 1995 Using retrospective behavioral data to determine HIV risk factors among street-recruited drug injectors. Journal of Drug Issues 25:161-171.
14. Diaz, T., S.Y. Chu, B. Weinstein, E. Mokotoff, and T.S. Jones 1998 Injection and syringe sharing among HIV-infected injection drug users: Implications for prevention of HIV transmission. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18 (Suppl 1):S76-S81.
15. Dowling-Guyer, S., M.E. Johnson, D.G. Fisher, R. Needle, J.K. Watters, M. Anderson, M. Williams, L. Kotranski, R. Booth, F. Rhodes, N. Weatherby, A.L. Estrada, D. Fleming, S. Deren, and S. Tortu 1994 Reliability of drug users' self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment 1:383-392.
16. Feldman, H.W. and P. Biernacki 1988 The ethnography of needle sharing among intravenous drug users and implications for public policies and intervention strategies. In Needle Sharing among Intravenous Drug Abusers: National and International Perspectives, R.J. Battjes and R.W. Pickens (eds.). NIDA Research Monograph 80, 28-39. Rockville, MD: National Institute on Drug Abuse.
17. Friedman, S.R., J.L. Sotheran, A. Abdul-Quader, D.C. Des Jarlais, P. Kleinman, C. Mauge, D.S. Goldsmith, W. El-Sadr, and R. Maslansky 1987 The AIDS epidemic among Blacks and Hispanics. Milbank Quarterly 65 (suppl. 2):455-499.
18. Gleghorn, A.A., T.S. Jones, M.C. Doherty, D.D. Celentano, and D. Vlahov 1995 Acquisition and use of needles and syringes by injecting drug users in Baltimore, Maryland. Journal of Acquired Immune Deficiency and Human Retrovirology 10:97-103.
19. Gostin, L.O. and Z. Lazzarini 1997 Prevention of HIV/AIDS among injection drug users: The theory and science of public health and criminal justice approaches to disease prevention. Emory Law Journal 46:587-696.
20. Groseclose, S.L., B. Weinstein, T.S. Jones, L.A. Valleroy, L.J. Fehrs, and W.J. Kassler 1995 Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers - Connecticut, 1992-1993. Journal of Acquired Immune Deficiency and Human Retrovirology 10:82-89.
21. Grund, J.-P.C., D.D. Heckathorn, R.S. Broadhead and D.L. Anthony 1995 In Eastern Connecticut, IDUs purchase syringes from pharmacies but don't carry syringes. [letter]. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10:104-105.
22. Holmberg, S. 1996 The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. American Journal of Public Health 86:642-654.
23. Koester, S.K. 1994 Copping, running, and paraphernalia laws: Contextual variables and needle risk behaviors among injection drug users in Denver. Human Organization 53:287-295.
24. Kral, A.H., J. Lorvick, and R.N. Bluthenthal 1996 Impact of drug paraphernalia laws in Bayview/Hunter's Point. In 1st National Harm Reduction Conference. Oakland, California.
25. Latkin, C.A., D. Vlahov, and J.C. Anthony 1993 Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction 88:517-526.
26. Levine, O.S., D. Vlahov, and K.E. Nelson 1994 Epidemiology of hepatitis B virus infection among injection drug users: Seroprevalence, risk factors, and viral interactions. Epidemiologic Reviews 16:418-436.
27. Lewis, D.K. and J.K. Watters 1989 Human immunodeficiency virus seroprevalence in female intravenous drug users: The puzzle of black women's risk. Social Science and Medicine 29:1071-1076.
28. Lurie, P. and E. Drucker 1997 An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. Lancet 349:604-608.
29. Lurie, P., A.L. Reingold, B. Bowser, D. Chen, J. Foley, J. Guydish, J.G. Kahn, S. Lane, and J. Sorenson 1993 The Public Health Impact of Needle Exchange Programs in the United States and Abroad. San Francisco, CA: University of California.
30. Mangaliman, J. 1994 New needle battle: Fear, arrests hurting AIDS fight. Newsday, July 12.
31. Maybury, J. 1995 Council members become outlaws to needle police. Oakland Tribune, January 22, 1995.
32. Nelson, K.E., D. Vlahov, S. Cohn, A. Lindsay, L. Solomon, and J.C. Anthony 1991 Human immunodeficiency virus infection in diabetic intravenous drug users. Journal of the American Medical Association 266:2259-2261.
33. Norvick, D.M., H.L. Trigg, D.C. Des Jarlais, S.R. Friedman, D. Vlahov, and M.J. Kreek 1989 Cocaine injection and ethnicity in parenteral drug users during the early years of the human immunodeficiency virus (HIV) epidemic in New York City. Journal of Medical Virology 29:181-185.
34. Paone, D., D.C. Des Jarlais, J. Clark, and Q. Shi 1997 United States syringe exchange program survey, 1995-1996. In 7th North American Syringe Exchange Conference. San Diego, CA.
35. Rich, J.D., B.P. Dickinson, K.-L. Liu, P. Case, B. Jesdale, R.M. Ingegneri, and P.A. Nolan 1998 Strict syringe laws in Rhode Island are associated with high rates of reusing syringes and HIV risks among injection drug users. [letter]. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18(suppl 1):S140-S141.
36. Schutz, C.G., D. Vlahov, J.C. Anthony, and N.M.H. Graham 1994 Comparison of self-reported injection frequencies for past 30 days and 6 months among intravenous drug users. Journal of Clinical Epidemiology 47:191-195.
37. Singer, M., M.R. Weeks, and D. Himmelgreen 1995 Sale and exchange of syringes. [letter]. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10:104.
38. Squatriglia, C. 1995 Volunteers use needles to save addicts. West County Times, November 1, 1995.
39. U.S. Preventive Services Task Force 1996 Guide to Clinical Preventive Services. 2nd ed. Baltimore, MD: Williams and Wilkins.
40. U.S. Public Health Service 1997 HIV prevention bulletin: Medical advice for persons who inject illicit drugs. Atlanta, GA: Centers for Disease Control and Prevention.
41. Veal, G.R. 1981 The Model Drug Paraphernalia Act: Can we outlaw head shops - and should we? Georgia Law Review 16:137-139.
42. Vlahov, D., B. Junge, R. Brookmeyer, S. Cohn, E. Riley, H. Armenian, and P. Beilenson 1997 Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 16:400-406.
43. Waldorf, D., C. Reinarman, and S. Murphy 1990 Needle sharing, shooting galleries, and AIDS risks among intravenous drug users in San Francisco: Criminal justice and public health policy. Criminal Justice Policy Review 3:321-343.
44. Watters, J.K. and P. Biernacki 1989 Targeted sampling: Options for the study of hidden populations. Social Problems 36:416-430.
45. Watters, J.K., R.N. Bluthenthal, and A.H. Kral 1995 HIV seroprevalence in injection drug users. [letter]. Journal of the American Medical Association 273:1178.
46. Watters, J.K., M.J. Estilo, G.L. Clark, and J. Lorvick 1994 Syringe and needle exchange as HIV/AIDS prevention for injection drug users. Journal of the American Medical Association 271:115-120.
47. Wright, L.N. and K.M. Gebbie 1998 Oregon's exclusion of syringes from its 1987 drug paraphernalia law was an HIV prevention measure. [letter]. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18(suppl 1):S144-S145.
48. Zule, W. 1992 Risk and reciprocity: HIV and the injection drug user. Journal of Psychoactive Drugs 24:243-249.